Document is current
Any future updates will be listed below
-
Authors
Čelutkienė, Jelena
Burneikaitė, Greta
Shkolnik, Evgeny
Jakutis, Gabrielius
Vajauskas, Donatas
Čerlinskaitė, Kamilė
Zuozienė, Gitana
Petrauskienė, Birutė
Puronaitė, Roma
Komiagienė, Renata
Butkuvienė, Irena
Steponėnienė, Rima
Misiūra, Jonas
Laucevičius, Aleksandras
- License Information
-
More Information
Article History
Received: 13 April 2019
Accepted: 12 June 2019
First Online: 4 July 2019
Ethics approval and consent to participate
: Vilnius Regional Ethics Committee approved the study (Approval No. 158200–13–616-187) and written consent was obtained from all patients prior to the enrolment.
: Not applicable.
: GB has received investigator fees from Sanofi, Janssen Research, and Daichii Sankyo; has received research support from Medispec (applicators for this study). ES has received consulting fee and research support from Medispec (applicators for this study); has received investigator fees from Servier and Bayer. GZ has received research support from Medispec for Cardiac Shock wave study. BP is a member of steering committee for Novartis and Janssen Research; has received speaker fees from Remedica, Astra Zeneca, Pfizer, Bayer and Boehringer -Ingelheim. JC is a member of advisory board for Novartis; has received investigator fees from Amgen, Sanofi and Servier; has received research support from Medispec (applicators for this study). GJ, DV, KČ, RK, IB, RS, JM, and AL have no competing interest.
